These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20507095)

  • 1. From sensors to silencers: quinoline- and benzimidazole-sulfonamides as inhibitors for zinc proteases.
    Rouffet M; de Oliveira CA; Udi Y; Agrawal A; Sagi I; McCammon JA; Cohen SM
    J Am Chem Soc; 2010 Jun; 132(24):8232-3. PubMed ID: 20507095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating chelating sulfonamides and their use in metalloproteinase inhibitors.
    Tanakit A; Rouffet M; Martin DP; Cohen SM
    Dalton Trans; 2012 Jun; 41(21):6507-15. PubMed ID: 22411188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sulfonamide group in matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Xu WF
    Curr Med Chem; 2008; 15(4):368-73. PubMed ID: 18288991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
    Jacobsen JA; Fullagar JL; Miller MT; Cohen SM
    J Med Chem; 2011 Jan; 54(2):591-602. PubMed ID: 21189019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific interactions between zinc metalloproteinase and its inhibitors: Ab initio fragment molecular orbital calculations.
    Ara A; Kadoya R; Ishimura H; Shimamura K; Sylte I; Kurita N
    J Mol Graph Model; 2017 Aug; 75():277-286. PubMed ID: 28618335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.
    Scozzafava A; Supuran CT
    J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new role for old ligands: discerning chelators for zinc metalloproteinases.
    Jacobsen FE; Lewis JA; Cohen SM
    J Am Chem Soc; 2006 Mar; 128(10):3156-7. PubMed ID: 16522091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase.
    Jamloki A; Karthikeyan C; Hari Narayana Moorthy NS; Trivedi P
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3847-54. PubMed ID: 16682189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in matrix metalloproteinase inhibitors based on pyrrolidine scaffold.
    Cheng XC; Wang Q; Fang H; Xu WF
    Curr Med Chem; 2008; 15(4):374-85. PubMed ID: 18288992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New heteroarylbenzenesulphonamides as matrix metalloproteinase inhibitors.
    Delbecq F; Cordonnier G; Pommery N; Barbry D; Hénichart JP
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1119-21. PubMed ID: 14980648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quest for selectivity in inhibition of matrix metalloproteinases.
    Brown S; Meroueh SO; Fridman R; Mobashery S
    Curr Top Med Chem; 2004; 4(12):1227-38. PubMed ID: 15320723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.
    Levin JI; Gu Y; Nelson FC; Zask A; DiJoseph JF; Sharr MA; Sung A; Jin G; Cowling R; Chanda P; Cosmi S; Hsiao CL; Edris W; Wilhelm J; Killar LM; Skotnicki JS
    Bioorg Med Chem Lett; 2001 Jan; 11(2):239-42. PubMed ID: 11206468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation.
    Nuti E; Santamaria S; Casalini F; Yamamoto K; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Marini AM; Salerno S; Taliani S; Da Settimo F; Nagase H; Rossello A
    Eur J Med Chem; 2013 Apr; 62():379-94. PubMed ID: 23376997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors.
    Nuti E; Tuccinardi T; Rossello A
    Curr Pharm Des; 2007; 13(20):2087-100. PubMed ID: 17627541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.
    Levin JI; Du MT; DiJoseph JF; Killar LM; Sung A; Walter T; Sharr MA; Roth CE; Moy FJ; Powers R; Jin G; Cowling R; Skotnicki JS
    Bioorg Med Chem Lett; 2001 Jan; 11(2):235-8. PubMed ID: 11206467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the development of matrix metalloproteinase inhibitors.
    Tu G; Xu W; Huang H; Li S
    Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors.
    Grams F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi V; Menta E; Oliva A; Zimmermann G; Gram F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi VMenta E; Oliva A; Zimmermann G
    Biol Chem; 2001 Aug; 382(8):1277-85. PubMed ID: 11592410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.
    O'Brien PM; Ortwine DF; Pavlovsky AG; Picard JA; Sliskovic DR; Roth BD; Dyer RD; Johnson LL; Man CF; Hallak H
    J Med Chem; 2000 Jan; 43(2):156-66. PubMed ID: 10649971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies.
    Fischer T; Riedl R
    Int J Mol Sci; 2016 Mar; 17(3):314. PubMed ID: 26938528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydantoin based inhibitors of MMP13--discovery of AZD6605.
    De Savi C; Waterson D; Pape A; Lamont S; Hadley E; Mills M; Page KM; Bowyer J; Maciewicz RA
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4705-12. PubMed ID: 23810497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.